Annual Cash & Cash Equivalents
$23.71 M
+$12.76 M+116.47%
December 31, 2023
Summary
- As of March 6, 2025, BOLD annual cash & cash equivalents is $23.71 million, with the most recent change of +$12.76 million (+116.47%) on December 31, 2023.
- During the last 3 years, BOLD annual cash & cash equivalents has fallen by -$10.58 million (-30.86%).
- BOLD annual cash & cash equivalents is now -30.86% below its all-time high of $34.29 million, reached on December 1, 2021.
Performance
BOLD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$40.21 M
+$8.85 M+28.22%
September 30, 2024
Summary
- As of March 6, 2025, BOLD quarterly cash and cash equivalents is $40.21 million, with the most recent change of +$8.85 million (+28.22%) on September 30, 2024.
- Over the past year, BOLD quarterly cash and cash equivalents has increased by +$19.25 million (+91.82%).
- BOLD quarterly cash and cash equivalents is now -2.67% below its all-time high of $41.32 million, reached on June 1, 2023.
Performance
BOLD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BOLD Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +116.5% | +91.8% |
| 3 y3 years | -30.9% | +91.8% |
| 5 y5 years | -30.9% | +91.8% |
BOLD Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.9% | +116.5% | -2.7% | +267.2% |
| 5 y | 5-year | -30.9% | +116.5% | -2.7% | +267.2% |
| alltime | all time | -30.9% | +116.5% | -2.7% | +267.2% |
Boundless Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $40.21 M(+28.2%) |
| Jun 2024 | - | $31.36 M(+24.7%) |
| Mar 2024 | - | $25.14 M(+6.1%) |
| Dec 2023 | $23.71 M | $23.71 M(+13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $20.96 M(-49.3%) |
| Jun 2023 | - | $41.32 M(+277.3%) |
| Dec 2022 | $10.95 M(-68.1%) | - |
| Dec 2022 | - | $10.95 M |
| Dec 2021 | $34.29 M | - |
FAQ
- What is Boundless Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Boundless Bio?
- What is Boundless Bio annual cash & cash equivalents year-on-year change?
- What is Boundless Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Boundless Bio?
- What is Boundless Bio quarterly cash and cash equivalents year-on-year change?
What is Boundless Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of BOLD is $23.71 M
What is the all time high annual cash & cash equivalents for Boundless Bio?
Boundless Bio all-time high annual cash & cash equivalents is $34.29 M
What is Boundless Bio annual cash & cash equivalents year-on-year change?
Over the past year, BOLD annual cash & cash equivalents has changed by +$12.76 M (+116.47%)
What is Boundless Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BOLD is $40.21 M
What is the all time high quarterly cash and cash equivalents for Boundless Bio?
Boundless Bio all-time high quarterly cash and cash equivalents is $41.32 M
What is Boundless Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, BOLD quarterly cash and cash equivalents has changed by +$19.25 M (+91.82%)